The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the sector. A shift away from Schedule I status, often regarded as outdated and hindering https://bookmarkinglog.com/story20757648/marijuana-rescheduling-a-growth-catalyst